Clara Bodelon, Ph.D., M.S., joined DCEG as a postdoctoral fellow in January 2011. She received her Ph.D. in mathematics from Boston University in 2001. From 2002 to 2006, Dr. Bodelon did postdoctoral research at The Salk Institute (La Jolla, CA) attempting to understand the dynamics of visual processing. In 2009, Dr. Bodelon received a Master of Science degree in epidemiology from the University of Washington. While working on this degree, she examined the association between the use of analgesics and the risk of endometrial cancer. She also studied relationships between hormonally-related factors and esophageal cancer and the immunogenetic susceptibility of cervical and vulvar cancers. In her current appointment within the Hormonal and Reproductive Epidemiology Branch (HREB), she is working with Nicolas Wentzensen, M.D., Ph.D., Senior Investigator, HREB, on projects related to the molecular epidemiology of ovarian cancer.
Ronald Eldridge, Ph.D., M.P.H., joined the Hormone and Reproductive Epidemiology Branch (HREB) in September of 2014 as a NCI Cancer Prevention Fellow. Prior to joining the branch, he obtained his B.S. in biology from Loyola University Chicago, and his M.P.H. and Ph.D. in epidemiology from Emory University. During his graduate studies, he conducted research in the fields of breast, colorectal, and pancreatic cancers by investigating the genetic, behavioral, and demographic causes of those cancers. His doctoral dissertation examined the harmful effects oxidative stress has on colorectal adenoma, and how obesity increases adenoma risk through the oxidative stress process. Here at the NCI, Dr. Eldridge will continue to pursue his research interests of mediation analysis and molecular mechanisms, primarily in gynecological cancers. He is currently working under the mentorship of Nicolas Wentzensen, M.D., Ph.D., Senior Investigator, HREB, and Sholom Wacholder, Ph.D., Senior Investigator, Biostatistics Branch. With their guidance, Dr. Eldridge is clarifying the molecular and epidemiologic reasons that increase a woman’s risk of cervical and endometrial cancers.
Armen Ghazarian, M.P.H., joined the Hormonal and Reproductive Epidemiology Branch (HREB) as a predoctoral fellow in September 2012 as part of the collaborative doctoral training partnership in cancer epidemiology with George Washington University. Prior to joining HREB, he worked in NCI’s Division of Cancer Control and Population Sciences (DCCPS) as an environmental epidemiology CRTA fellow. Mr. Ghazarian attended the University of Maryland, College Park where he received a B.S. in biological sciences in 2008 followed by an M.P.H. in epidemiology in 2011. His master’s thesis focused on socioeconomic disparities of esophageal adenocarcinoma using data from NCI’s Surveillance, Epidemiology, and End Results (SEER) Program. His research interests include cancer and environmental epidemiology, gene and environment interactions, endocrine disruptors, social determinants of health, and hormonally-related cancers including prostate and testicular. Mr. Ghazarian is working with Katherine A. McGlynn, Ph.D., M.P.H., Deputy Chief of HREB, and Britton Trabert, Ph.D., M.S., Investigator, HREB, on studies of male cancers.
Shivani Jain joined the Hormonal and Reproductive Epidemiology Branch (HREB) as a pre-doctoral fellow in June 2015. Ms. Jain earned a master’s degree with distinction in global health and development from the University College London in 2012 and a master’s degree with distinction in epidemiology from the University of Cambridge in 2013. Ms. Jain is currently enrolled in a doctoral program at the University of Cambridge through the NIH/Oxford/Cambridge Scholars Program. In DCEG, Ms. Jain initially worked with Sam Mbulaiteye, MBChB, M.Phil., M.Med., senior investigator in the Infections and Immunology Branch, evaluating the role of cytoadherence of Plasmodium falciparum-infected erythrocytes in Burkitt lymphoma using a genomics approach. In HREB, she is working with Nicolas Wentzensen, M.D., Ph.D., senior investigator, to develop a series of polygenic risk models for ovarian cancer using the OCAC OncoArray data, in addition to other preciously unused resources. She is also working on the improvement of penalized methods for SNP selection and the evaluation of three different annotation methods as they apply to ovarian cancer risk.
Scott Kelly, M.S. joined the Hormonal and Reproductive Epidemiology Branch (HREB) as a predoctoral fellow in November 2013 as part of the collaborative doctoral training partnership in cancer epidemiology with George Washington University. Mr. Kelly received his M.S. in biostatistics and epidemiology from Georgetown University in 2009. His master’s thesis focused on risk factors of congenital cardiovascular malformations for infants born in the mid-Atlantic region of the United States. Prior to joining the branch, he worked as a biostatistician and data manager within the Cancer Prevention and Control program of the Lombardi Comprehensive Cancer Center at Georgetown University. His research interests include genetic, hormonal, lifestyle and environmental factors that modify prostate cancer risk, progression, and survival outcomes. For his doctoral dissertation, Mr. Kelly is working with Michael B. Cook, Ph.D., Investigator, HREB, on research pertaining to the role of hormonal and genetic mechanisms in the pathogenesis of prostate cancer, as well as novel analyses of incidence trends and survival rates.
Angela Liu, B.S., joined the Hormonal and Reproductive Epidemiology Branch (HREB) as a medical research scholar through the Medical Research Scholar Program (MRSP) in August 2014. She received her bachelor of science in neuroscience with a minor in biomedical research from the University of California, Los Angeles in 2010. She is a medical doctoral candidate at University of California, San Diego, currently on an away research fellowship for the school year of 2014-2015. She studied receptor-tyrosine kinase signal transduction and intra-tumoral heterogeneity in glioblastoma as an undergraduate researcher in Dr. Paul Mischel’s laboratory at UCLA (2006-2010), and later as a medical student researcher in Dr. Cameron Brennan’s laboratory at the Memorial-Sloan Kettering Cancer Center (2012). Ms. Liu also studied the role of CD44 alternative-splicing in the epidermal-mesenchymal transition (EMT) in breast cancer, as well as CD44 alternative splicing in Kras-driven lung adenocarcinoma in Dr. Chonghui Cheng’s lab at Northwestern University, Feinberg School of Medicine (2010-2011). As a medical research fellow in HREB, Ms. Liu’s research focuses on cervical cancer risk stratification. Specifically, she is working with senior investigator Dr. Nicolas Wentzensen, M.D., Ph.D., on The Biopsy Project to study the determinants of colposcopy impression and biopsy placement in women with abnormal cervical cancer screening results.
Maeve Mullooly, Ph.D., M.P.H., joined the Hormonal and Reproductive Epidemiology Branch (HREB) as an NCI Cancer Prevention Fellow. Dr. Mullooly received her B.Sc. in pharmacology from University College Dublin (UCD) in Ireland, followed by her Ph.D. in translational medicine from St. Vincent’s University Hospital and UCD’s School of Medicine and Medical Science. During her doctoral studies, she investigated proteases as novel therapeutic targets for breast cancer with a focus on triple negative breast cancer. Her project formed part of the strategic multicenter and multidisciplinary research cluster “Molecular Therapeutics for Cancer Ireland” funded by Science Foundation Ireland. Dr. Mullooly recently completed her M.P.H. at UCD’s School of Public Health, Physiotherapy and Population Science. During her fellowship in HREB, Dr. Mullooly is focusing on molecular epidemiologic studies of breast density and breast cancer, working primarily with HREB investigator Gretchen Gierach, Ph.D.,M.P.H., Investigator, HREB.
Hannah Oh, Sc.D., M.P.H., joined the Hormonal and Reproductive Epidemiology Branch (HREB) as a postdoctoral fellow in December 2014. Prior to joining the branch, Dr. Oh received a B.A. in molecular and cell biology from the University of California, Berkeley, an M.P.H. in global health from Emory University (2010), and an Sc.D. in epidemiology and nutrition from Harvard University (2014). Her doctoral dissertation focused on lifestyle factors (physical activity, body fatness, diet) and hormones in relation to breast cancer. In HREB, she is working with Gretchen Gierach, Ph.D., M.P.H., investigator, HREB, on projects related to mammographic density and terminal duct lobular unit (TDLU) involution in normal breast tissue to identify markers that may improve risk assessment and early detection of breast cancer. She is also working with Britton Trabert, Ph.D., M.S., investigator, HREB, on projects related to sex steroid hormone metabolites (e.g., estrogen metabolites) and studies of endometrial and ovarian cancer.
Jessica L. Petrick, Ph.D., M.P.H., joined the Hormonal and Reproductive Epidemiology Branch (HREB) as a postdoctoral fellow in June 2014. She obtained a B.A. in public health studies and medical anthropology, and an M.P.H. (2008) in epidemiology and health policy from Case Western Reserve University. Dr. Petrick received her Ph.D. in epidemiology from the University of North Carolina at Chapel Hill in 2014. For her doctoral dissertation, Dr. Petrick examined the intake of dietary flavonoids in relation to the incidence of Barrett esophagus and esophageal and gastric cancer, and to survival among esophageal and gastric cancer cases. Her Ph.D. mentor was Dr. Marilie Gammon. In HREB, Dr. Petrick works with Katherine A. McGlynn, Ph.D., Deputy Chief of HREB, on liver cancer studies assessing gender-specific effects of risk factors such as coffee consumption, diabetes, obesity and steroid hormone levels, and with Michael B. Cook, Ph.D., Investigator, HREB on the effects of adiposity on esophageal adenocarcinoma risk.
Baiyu Yang, Ph.D., joined the Hormonal and Reproductive Epidemiology Branch (HREB) as a postdoctoral fellow in July 2015. Prior to joining the branch, Dr. Yang obtained her Bachelor of Medicine (B.Med.) in preventive medicine from Fudan University, China (2010), and her Ph.D. in epidemiology from Emory University (2015). For her doctoral dissertation research, she investigated the role of calcium consumption in relation to biomarkers of risk for colorectal cancer and other chronic diseases, survival from colorectal cancer, and risk for all-cause and cause-specific mortality. She also worked with the American Cancer Society to explore other risk factors associated with colorectal cancer survival. In HREB, Dr. Yang works with Katherine A. McGlynn, Ph.D., Deputy Chief and senior investigator, HREB, applying her clinical and epidemiologic training to the study of the gut-liver axis, including the role of inflammation, obesity, diabetes, and medication use in the development of liver cancer.
Cindy Zhou, Ph.D., joined the Hormonal and Reproductive Epidemiology Branch (HREB) as a predoctoral fellow in October 2012. In 2010, she received her Bachelor of Medicine (B.Med.) in preventive medicine from the West China Center of Medical Sciences, Sichuan University, China. For her B.Med. research project, Dr. Zhou examined socioeconomic and behavioral factors in breast cancer screening among women in southwest China. In 2008 – 2009, she served as a resident in the West China Hospital, Sichuan, China, rotating through the Departments of Oncology, Rehabilitation, Gerontology and General Medicine. In the summer of 2009, Dr. Zhou was an intern with the Center for Disease Control and Prevention in Zigong, China, working on the HIV/AIDS Sentinel Surveillance program. In 2011, she worked on several projects related to prostate cancer with Dr. Ann Hsing, formerly a senior investigator in the Infections and Immunoepidemiology Branch. For her doctoral dissertation, Dr. Zhou worked with HREB investigator Michael B. Cook, Ph.D., Investigator, HREB, on research pertaining to the etiology of prostate cancer. She recently received her Ph.D. from the Department of Epidemiology and Biostatistics at George Washington University School of Public Health and Health Services.